These findings are similar to the CNA reported by Boi et al using SNP array analysis in a cohort of ALCL (ALK+ and ALK−) patients26, while differing from the genomic imbalances described in earlier studies that used GCH arrays that included gains of 2p, 7p, 17p and 17q, and losses of 4q, 11q and 13q76. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.